Martín-Nalda, Andrea
Fortuny, Claudia
Rey, Lourdes
Bunney, Tom D.
Alsina, Laia
Esteve-Solé, Ana
Bull, Daniel
Anton, Maria Carmen
Basagaña, María
Casals, Ferran
Deyá, Angela
García-Prat, Marina
Gimeno, Ramon
Juan, Manel
Martinez-Banaclocha, Helios
Martinez-Garcia, Juan J
Mensa-Vilaró, Anna
Rabionet, Raquel
Martin-Begue, Nieves
Rudilla, Francesc
Yagüe, Jordi
Estivill, Xavier
García-Patos, Vicente
Pujol, Ramon M.
Soler-Palacín, Pere
Katan, Matilda
Pelegrín, Pablo
Colobran, Roger
Vicente, Asun
Arostegui, Juan I.
Funding for this research was provided by:
Generalitat de Catalunya (CERCA Programme/)
Ministerio de Economía y Competitividad (SAF2015-68472-C2-1-R, PI13/00174)
Ministerio de Ciencia, Innovación y Universidades (RTI2018-096824-B-C21)
Instituto de Salud Carlos III (AC15/00027, PI14/00405, CM14/00008)
Ministerio de Economía y Competitividad (SAF2017-88276-R, SAF2015-68472-C2-2-R)
FP7 Ideas: European Research Council (ERC-2013-CoG project 614578)
Fundación Séneca (20859/PI/18)
Ministerio de Ciencia, Innovación y Universidades (RTI2018-096824-B-C22)
Medical Research Council (P028160)
Cancer Research UK (A16567)
University College London (UCL Impact Studentship)
Article History
Received: 10 January 2020
Accepted: 20 May 2020
First Online: 15 July 2020
Compliance with Ethical Standards
: The ethics committees of Hospital Sant Joan de Déu, Hospital Universitari Vall d’Hebron, and Hospital Clínic, all in Barcelona (Spain), approved the study. Written informed consent for participation in the study was obtained from patients’ parents. Blood samples from patients and unaffected relatives were collected for molecular studies, which were performed in accordance with the Declaration of Helsinki.
: The authors declare that they have no conflict of interest.